Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
Recruiting · NCT06437158 · Registry updated 2024-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, lymphatic malformation, lymphatic system disorder | Recruiting | Phase 2 | 2024-06-03 | NCT06437158 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| West China Hospital | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital of Sichuan University | Chengdu | China | 117 |